(2-amino-1,3-thiazol-4-yl)methanol hydrochloride, 95.0%, 1g

1,5-Dimethyl-1H-pyrazole-4-carboxylic acid, 97.0%, 5g

4-(4-Bromophenyl)oxane-4-carbonitrile, 95.0%, 250mg

2-(4-methylpiperidin-1-yl)propanoic acid, 95.0%, 5g

ethyl 3-bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate, 100mg

O-(Benzotriazol-1-yl)-N,N,N',N'-bis(pentamethylene)uronium Hexafluorophosphate>98.0%(HPLC)1g

1,3-Dimethyluracil, 98.0%, 500g

Ethyl 4-[(3-bromophenyl)sulfanyl]butanoate, 5g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 300m2/g)5g

Nonyl(phenyl)sulfane, 95.0%, 5g

8-thia-4,6-diazatricyclo[7.4.0.0�,?]trideca-1(9),2(7),5-triene-3-thione, 97%, 100mg

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine, 95.0%, 5g

(4-aminobutyl)(diazyn-1-ium-1-yl)azanide, 250mg